The celebrity dermatologist talks about finding her moment of clarity in finding relief for her eczema symptoms and how she ...

Nektar Therapeutics has completed target enrollment for its phase 2b study of rezpegaldesleukin for the treatment of patients ...

Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

Patients with atopic dermatitis aged 2 years and older who used tapinarof cream 1% had significant improvements in various patient-reported outcomes.

A South Korean study explored the link between lifestyle decisions beginning in infancy and persistent atopic dermatitis, ...

Apogee Therapeutics develops therapies for inflammatory autoimmune diseases. Find out why I'm bearish on APGE stock.

Comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA), according to a researc ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin disease that can cause significant discomfort for ...

The following is a summary of “Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients ...

rough and cracked patches of skin. But reports from a clinical trial of rocatinlimab – a monoclonal antibody therapy – for the treatment of moderate to severe atopic dermatitis has shown ...